2Schmidt CM, Matos JM, Bentrem D J, et al. Acinar cell carcinoma of the pancreas in the United States: prognos- tic factors and comparison to ductal adenocarcinoma[J]. J Gastrointest Surg, 2008,12(12): 2078-2086.
4Means AL, Meszoely IM, Suzuki K, et al. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates [J]. Development, 2005,132(16):3767-3776.
5Sawey ET, Johnson JA, Crawford HC. Matrix metalloproteinase 7 controls pancreatic acinar cell transdifferentiation by activating the Notch signaling pathway [J]. Proc Natl Acad Sci U S A, 2007,104(49):19327-19332.
6Seth AK, Argani P, Campbell KA, et al. Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature [J]. J Gastrointest Surg, 2008,12(6): 1061-1067.
7Wisnoski NC, Townsend CM Jr, Nealon WH, et al. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma[J]. Surgery, 2008,144(2): 141-148.
8Hoorens A, Lemoine NR, McLellan E, et al. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation[J]. Am J Pathol, 1993,143 (3):685 -698.
9Matos JM, Schmidt CM, Turrini O, et al. Pancreatic acinar cell carcinoma: a muhi-institutional study[J]. J Gastrointest Surg, 2009,13(8):1495-1502.
10Holen KD, Klimstra DS, Hummer A, et al. Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors [J]. J Clin Oncol, 2002,20(24):4673-4678.
